IMMUNE PROFILING EVALUATION OF NEWLY DIAGNOSE MULTIPLE MYELOMA (NDMM) TRANSPLANT ELIGIBLE (TE) PATIENTS TREATED WITH DARATUMUMAB, CYCLOPHOSPHAMIDE, THALIDOMIDE AND DEXAMETHASONE (DARA-CTD): PRELIMINARY RESULTS
| Autor: | A.S. Santos, H.H.M. Santos, M.A. Salvino, S.Q. Silva, L.F. Lucas, A.M. Almeida, M.M. Santos, M.G.B. Arruda, A.J.L. Torres, E.Q. Crusoe |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: | |
| Zdroj: | Hematology, Transfusion and Cell Therapy, Vol 42, Iss , Pp 261- (2020) |
| Druh dokumentu: | article |
| ISSN: | 2531-1379 |
| DOI: | 10.1016/j.htct.2020.10.437 |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|